21 results
8-K
EX-1.1
VERV
Verve Therapeutics Inc
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
Adverse Effect. “Hazardous Materials” means any material, chemical, substance, waste, pollutant, contaminant, compound, mixture, or constituent thereof
8-K
EX-1.1
9gi1 bilvqzd54mzuqe
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
S-3
EX-1.2
e1m y74ahybush3
1 Jul 22
Shelf registration
4:36pm
10-K
bvd10 97qgo
14 Mar 22
Annual report
7:04am
10-Q
lsey44q
12 Aug 21
Quarterly report
8:53am
424B4
b8qegbc9
17 Jun 21
Prospectus supplement with pricing info
4:50pm
S-1/A
EX-1.1
qm5ztebo44ep
14 Jun 21
IPO registration (amended)
6:15am
S-1/A
u4vri4ig
14 Jun 21
IPO registration (amended)
6:15am
S-1
r1nz3d uvk
28 May 21
IPO registration
4:04pm